ProKidney Corp. (PROK) NASDAQ

2.68

-0.01(-0.37%)

Updated at July 31 10:27AM

Currency In USD

ProKidney Corp.

Address

2000 Frontis Plaza Blvd.

Winston-Salem, NC 27103

United States of America

Phone

336 999 7028

Sector

Healthcare

Industry

Biotechnology

Employees

204

First IPO Date

June 30, 2021

Key Executives

NameTitlePayYear Born
Dr. Bruce Culleton M.D.Chief Executive Officer & Director1.02M1969
Mr. James Coulston CPAChief Financial Officer533,1521977
Dr. Ulrich Ernst Ph.D.EVice President of Science and Technology622,7431963
Mr. Todd C. Girolamo Esq., J.D., M.B.A.Chief Legal Officer & Secretary635,8581965
Dr. Joseph M. Stavas M.D., M.P.H.SVice President of Clinical Affairs0N/A
Ms. Anu BiswasSenior Vice President of Manufacturing & Operations0N/A
Mr. Richard WilliamsChief Information Officer0N/A
Mr. Nikhil L. Pereira-KamathChief Business Officer0N/A
Ms. Carla PoulsonChief People Officer0N/A
Dr. Darin J. Weber Ph.D.Chief Reg. Off, SVice President and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access01968

Description

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.